at resmed (nyse: rmd, asx: rmd) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. our cloud-connected medical devices transform care for people with sleep apnea, copd and other chronic diseases. our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. by enabling better care, we improve quality of life, reduce the impact of chronic disease and lower costs for consumers and healthcare systems in more than 120 countries.
Financial Statements
- Click here to download Resmed Inc.'s Income Statement
- Click here to download Resmed Inc.'s Balance Sheet
- Click here to download Resmed Inc.'s Statement of Cash Flows
Key Info
- Industry: Surgical and Medical Instrument Manufacturing
- Sector: Manufacturing
- CEO Name: Michael Farrell
Key Statistics
- Stock Price: $198.03
- Dividend Yield: 0.8999999999999999%
- Market Capitalization: $29,128,012,491
- Shares Outstanding: 147,088,888
- Number of Employees: 5,138
- Trailing 12-Month EPS: $6.03
- Trailing 12-Month DPS: $1.87
- Payout Ratio: 31.0%
Important Dates
- Next Earnings Date: 2024-04-25
- Next Ex-Dividend Date: 2024-02-07
Price Trends
- Current Stock Price: $198.03
- 52-week high: $241.04
- 52-week low: $131.49
- 200-day moving average: $165.41
- 50-day moving average: $186
Performance
- 1-Month Price Return: 13.8%
- 3-Month Price Return: 15.4%
- 6-Month Price Return: 34.7%
- 1-Year Price Return: -7.4%
- 2-Year Price Return: -19.0%
- 5-Year Price Return: 99.1%
Visit the Passiv Stock Directory
Data provided by IEX Cloud
For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast